GrowBLOX Sciences, Inc. (GBLX) – Cultivating Tur
Post# of 118
Posted On: 07/31/2015 10:53:29 PM
GrowBLOX Sciences, Inc. (GBLX) – Cultivating Turnkey Solutions for the Medical Cannabis Industry
GrowBLOX Sciences (“GB Sciences”) is a nature-inspired company employing a novel approach toward cannabis-based medicine. The company is focused on offering a turnkey business solution: transforming cannabis into safe and consistent medicine.
GB Sciences’ focus is on the research of indoor agriculture technology for the medical cannabis industry. The company merges state-of-the-art technologies in plant biology, cultivation and post-production processes in order to optimize safe, consistent medical cannabis. In doing so, the company is also pioneering technology, industry-leading processes, and a big data-driven clinical research and development algorithm in order to bring relief to patients in communities across the country.
As part of its efforts to lock in industry standards, GB Sciences is developing a comprehensive line of highly effective cannabis-based therapies ranging from custom medical compounds to consumer health and beauty products. GB Sciences’ cultivation methodology ensures a consistent ratio of the plant’s medicinal properties for each and every harvest. This is a critical factor when creating formulations for standardized therapeutic products.
GB Sciences’ drug development program also endeavors to unlock the path to drug discovery and to provide novel cannabinoid therapies to patients with critically unmet needs. The company is developing the GrowBLOX system, a proprietary technology that allows for controlled growing conditions for the manufacture of toxin-free, natural, and medicinal-grade cannabis and cannabis concentrates. Starting with certified, cannabis plant-derived ingredients from the GrowBLOX technology suite, GB Sciences tests proprietary ratios of active ingredients in an accelerated drug development program. It also focuses on the research, testing and development of FDA-approved medical treatments and nutraceuticals using extracts from the cannabis sativa plant.
GrowBLOX Sciences is gearing up to cultivate the medical cannabis industry in new ways. The company’s science and research efforts power discovery, its engineering and design activities bring ideas into the real world, and its big data methodology drives continuous improvement.
For more information, visit the company’s website at www.growblox.com
Please see disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.com
GrowBLOX Sciences (“GB Sciences”) is a nature-inspired company employing a novel approach toward cannabis-based medicine. The company is focused on offering a turnkey business solution: transforming cannabis into safe and consistent medicine.
GB Sciences’ focus is on the research of indoor agriculture technology for the medical cannabis industry. The company merges state-of-the-art technologies in plant biology, cultivation and post-production processes in order to optimize safe, consistent medical cannabis. In doing so, the company is also pioneering technology, industry-leading processes, and a big data-driven clinical research and development algorithm in order to bring relief to patients in communities across the country.
As part of its efforts to lock in industry standards, GB Sciences is developing a comprehensive line of highly effective cannabis-based therapies ranging from custom medical compounds to consumer health and beauty products. GB Sciences’ cultivation methodology ensures a consistent ratio of the plant’s medicinal properties for each and every harvest. This is a critical factor when creating formulations for standardized therapeutic products.
GB Sciences’ drug development program also endeavors to unlock the path to drug discovery and to provide novel cannabinoid therapies to patients with critically unmet needs. The company is developing the GrowBLOX system, a proprietary technology that allows for controlled growing conditions for the manufacture of toxin-free, natural, and medicinal-grade cannabis and cannabis concentrates. Starting with certified, cannabis plant-derived ingredients from the GrowBLOX technology suite, GB Sciences tests proprietary ratios of active ingredients in an accelerated drug development program. It also focuses on the research, testing and development of FDA-approved medical treatments and nutraceuticals using extracts from the cannabis sativa plant.
GrowBLOX Sciences is gearing up to cultivate the medical cannabis industry in new ways. The company’s science and research efforts power discovery, its engineering and design activities bring ideas into the real world, and its big data methodology drives continuous improvement.
For more information, visit the company’s website at www.growblox.com
Please see disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.com
(0)
(0)GB Sciences, Inc. (GBLX) Stock Research Links
Scroll down for more posts ▼